Recommended
Recommended
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Calyxo, Inc.

Calyxo Expands Board of Directors as Number of Patients Treated with its CVAC® System Crosses 20,000 Milestone
From Calyxo, Inc.
Via Business Wire
Calyxo Debuts Reverse Deflection CVAC System and Reveals Groundbreaking Two-Year ASPIRE Data at WCET 2025, Underscoring the Technology’s Role in Advancing Endourology
From Calyxo, Inc.
Via Business Wire
Real-World Experience and Pre-Clinical Data Presented at the American Urological Association 2025 Meeting Shed Light on the Unique Advantages of the CVAC System
From Calyxo, Inc.
Via Business Wire
Calyxo Celebrates One Year Anniversary of the Launch of 2nd Generation CVAC System at American Urological Association 2025 Meeting
From Calyxo, Inc.
Via Business Wire
Calyxo Announces New Data Demonstrating CVAC System Maximizes Stone Clearance While Maintaining Safe Intrarenal Pressure
From Calyxo, Inc.
Via Business Wire
ASPIRE Level 1 Outcomes Published Demonstrating Superior Stone Clearance with the SURE Procedure using the CVAC System vs. Standard Ureteroscopy
From Calyxo, Inc.
Via Business Wire
Calyxo Announces New ASPIRE 1-Year Study Results with CVAC System in Kidney Stone Clearance Indicating a Positive Clinical and Health Economic Impact in the Treatment of Urolithiasis
From Calyxo, Inc.
Via Business Wire
Study Presented at AUA Shows Superior Kidney Stone Clearance Rates for SURE Procedure Using Calyxo’s CVAC System vs Standard URS
From Calyxo, Inc.
Via Business Wire
Calyxo Announces FDA Clearance for New, Redesigned CVAC System
From Calyxo, Inc.
Via Business Wire
Calyxo Closes on $50 Million Equity Financing to Support Broad Launch of CVAC Kidney Stone Treatment
From Calyxo, Inc.
Via Business Wire
Newly Published Study Demonstrates Safety and Efficacy of Calyxo’s CVAC Aspiration System for Patients with Large Kidney Stones
From Calyxo, Inc.
Via Business Wire
Calyxo Raises $32.7 Million in Series C Financing to Support Novel Approach to Treating Kidney Stones
From Calyxo, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.